UB Paderborn / Katalog / Suche / in CDI

Identification and quantification of blood–brain barrier transporters in isolated rat brain microvessels

Journal of neurochemistry, 2018-09, Vol.146 (6), p.670-685

2018

Volltextzugriff (PDF)

Effect of metformin on plasma metabolite profile in the Copenhagen Insulin and Metformin Therapy (CIMT) trial

Diabetic medicine, 2018-07, Vol.35 (7), p.944-953

2018

Volltextzugriff (PDF)

Proteomic Quantification of Human Blood–Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia Patients

Molecular pharmaceutics, 2019-03, Vol.16 (3), p.1220-1233

2019

Volltextzugriff (PDF)

Quantification of Proteins Involved in Drug Metabolism and Disposition in the Human Liver Using Label-Free Global Proteomics

Molecular pharmaceutics, 2019-02, Vol.16 (2), p.632-647

2019

Volltextzugriff (PDF)

Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters

Clinical pharmacology and therapeutics, 2021-01, Vol.109 (1), p.222-232

2021

Volltextzugriff (PDF)

Quantitative Proteomic Map of Enzymes and Transporters in the Human Kidney: Stepping Closer to Mechanistic Kidney Models to Define Local Kinetics

Clinical pharmacology and therapeutics, 2021-11, Vol.110 (5), p.1389-1400

2021

Volltextzugriff (PDF)

Dealing With Variable Drug Exposure Due to Variable Hepatic Metabolism: A Proof‐of‐Concept Application of Liquid Biopsy in Renal Impairment

Clinical pharmacology and therapeutics, 2024-09, Vol.116 (3), p.814-823

2024

Volltextzugriff (PDF)

Quantification of Proteins Involved in Intestinal Epithelial Handling of Xenobiotics

Clinical pharmacology and therapeutics, 2021-04, Vol.109 (4), p.1136-1146

2021

Volltextzugriff (PDF)

In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition

The AAPS journal, 2022-01, Vol.24 (1), p.28-28, Article 28

2022

Volltextzugriff (PDF)

Proteomics of colorectal cancer liver metastasis: A quantitative focus on drug elimination and pharmacodynamics effects

British journal of clinical pharmacology, 2022-02, Vol.88 (4), p.1811-1823

2022

Volltextzugriff (PDF)

Quantitative Proteomics of Hepatic Drug‐Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis

Clinical pharmacology and therapeutics, 2022-09, Vol.112 (3), p.699-710

2022

Volltextzugriff (PDF)

Mass spectrometry‐based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin

FEBS letters, 2020-12, Vol.594 (23), p.4134-4150

2020

Volltextzugriff (PDF)

Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis

Frontiers in oncology, 2023-02, Vol.13, p.1010563-1010563

2023

Volltextzugriff (PDF)

Quantification of the Proteins of the Bacterial Ribosome Using QconCAT Technology

Journal of proteome research, 2014-03, Vol.13 (3), p.1211-1222

2014

Volltextzugriff (PDF)

Mass spectrometric and peptide chip characterization of an assembled epitope: analysis of a polyclonal antibody model serum directed against the Sjøgren/systemic lupus erythematosus autoantigen TRIM21

Journal of mass spectrometry., 2013-06, Vol.48 (6), p.651-659

2013

Volltextzugriff (PDF)

Metabolite profiling of obese individuals before and after a one year weight loss program

International Journal of Obesity, 2017-09, Vol.41 (9), p.1369-1378

2017

Volltextzugriff (PDF)

Inhibition of aggregation of amyloid-β through covalent modification with benzylpenicillin; potential relevance to Alzheimer's disease

Biochemistry and biophysics reports, 2021-07, Vol.26, p.100943, Article 100943

2021

Volltextzugriff (PDF)

Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment

Molecular pharmaceutics, 2021-09, Vol.18 (9), p.3563-3577

2021

Volltextzugriff (PDF)

Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine

Drug metabolism and disposition, 2020-04, Vol.48 (4), p.245-254

2020

Volltextzugriff (PDF)

Proteomic Quantification of Changes in Abundance of Drug-Metabolizing Enzymes and Drug Transporters in Human Liver Cirrhosis: Different Methods, Similar Outcomes

Drug metabolism and disposition, 2021-08, Vol.49 (8), p.610-618

2021

Volltextzugriff (PDF)

Quantitative Assessment of the Impact of Crohn's Disease on Protein Abundance of Human Intestinal Drug-Metabolising Enzymes and Transporters

Journal of pharmaceutical sciences, 2022-10, Vol.111 (10), p.2917-2929

2022

Volltextzugriff (PDF)

Examining Physiologically Based Pharmacokinetic Model Assumptions for Cross-Tissue Similarity of Activity per Unit of Enzyme: The Case Example of Uridine 5′-Diphosphate Glucuronosyltransferase

Drug metabolism and disposition, 2022-08, Vol.50 (8), p.1119-1125

2022

Volltextzugriff (PDF)

Scaling Factors for Clearance in Adult Liver Cirrhosis

Drug metabolism and disposition, 2020-12, Vol.48 (12), p.1271-1282

2020

Volltextzugriff (PDF)

Hepatic Scaling Factors for In Vitro-In Vivo Extrapolation of Metabolic Drug Clearance in Patients with Colorectal Cancer with Liver Metastasis

Drug metabolism and disposition, 2021-07, Vol.49 (7), p.563-571

2021

Volltextzugriff (PDF)

Label-Free but Still Constrained: Assessment of Global Proteomic Strategies for the Quantification of Hepatic Enzymes and Transporters

Drug metabolism and disposition, 2022-06, Vol.50 (6), p.762-769

2022

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Identification and quantification of blood–brain barrier transporters in isolated rat brain microvessels

Effect of metformin on plasma metabolite profile in the Copenhagen Insulin and Metformin Therapy (CIMT) trial

Proteomic Quantification of Human Blood–Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia Patients

Quantification of Proteins Involved in Drug Metabolism and Disposition in the Human Liver Using Label-Free Global Proteomics

Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters

Quantitative Proteomic Map of Enzymes and Transporters in the Human Kidney: Stepping Closer to Mechanistic Kidney Models to Define Local Kinetics

Dealing With Variable Drug Exposure Due to Variable Hepatic Metabolism: A Proof‐of‐Concept Application of Liquid Biopsy in Renal Impairment

Quantification of Proteins Involved in Intestinal Epithelial Handling of Xenobiotics

In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition

Proteomics of colorectal cancer liver metastasis: A quantitative focus on drug elimination and pharmacodynamics effects

Quantitative Proteomics of Hepatic Drug‐Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis

Mass spectrometry‐based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin

Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis

Quantification of the Proteins of the Bacterial Ribosome Using QconCAT Technology

Mass spectrometric and peptide chip characterization of an assembled epitope: analysis of a polyclonal antibody model serum directed against the Sjøgren/systemic lupus erythematosus autoantigen TRIM21

Metabolite profiling of obese individuals before and after a one year weight loss program

Inhibition of aggregation of amyloid-β through covalent modification with benzylpenicillin; potential relevance to Alzheimer's disease

Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment

Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine

Proteomic Quantification of Changes in Abundance of Drug-Metabolizing Enzymes and Drug Transporters in Human Liver Cirrhosis: Different Methods, Similar Outcomes

Quantitative Assessment of the Impact of Crohn's Disease on Protein Abundance of Human Intestinal Drug-Metabolising Enzymes and Transporters

Examining Physiologically Based Pharmacokinetic Model Assumptions for Cross-Tissue Similarity of Activity per Unit of Enzyme: The Case Example of Uridine 5′-Diphosphate Glucuronosyltransferase

Scaling Factors for Clearance in Adult Liver Cirrhosis

Hepatic Scaling Factors for In Vitro-In Vivo Extrapolation of Metabolic Drug Clearance in Patients with Colorectal Cancer with Liver Metastasis

Label-Free but Still Constrained: Assessment of Global Proteomic Strategies for the Quantification of Hepatic Enzymes and Transporters

Suchergebnisse filtern